SCHEMBL7327181

SCHEMBL7327181

CC(C)[C@H](N)C(=O)C1(C(=O)c2ccc(Cl)cc2)CC[N]CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
BRD4 O60885 1/20 0.33
P2RX7 Q99572 1/20 0.33
HPGD P15428 1/20 0.33
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
CCR1 P32246 1/20 0.32
DPP4 P27487 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 2/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327175 1.00 ALDH1A1 (0.36) ALDH1A1SLC6A4SLC6A3BRD4P2RX7
SCHEMBL8391216 0.85 DRD2 (0.38) ALDH1A1SLC6A4SLC6A3P2RX7HPGD
SCHEMBL7327187 0.85 DRD2 (0.38) ALDH1A1SLC6A4SLC6A3P2RX7HPGD
SCHEMBL7325713 0.76 DRD3 (0.38) ALDH1A1P2RX7HPGDCES2CES1
SCHEMBL4674963 0.71 CES2 (0.42) ALDH1A1HPGDCES2CES1MEN1
SCHEMBL16235300 0.69 TRPA1 (0.47) ALDH1A1CES2CES1MEN1KMT2A
SCHEMBL16235100 0.69 TRPA1 (0.47) ALDH1A1CES2CES1MEN1KMT2A
Hydrochloric Acid SCHEMBL16234863 0.68 TRPA1 (0.46) ALDH1A1CES2CES1MEN1KMT2A
SCHEMBL7327084 0.66 MAPT (0.38) ALDH1A1P2RX7HPGDMAPTCYP2C19
SCHEMBL28626237 0.66 TSHR (0.50) ALDH1A1HPGDCES2CES1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed